Dr. Keon W. Kang, a nuclear medicine physician, is a professor and the Chairman of the Department of Nuclear Medicine, Seoul National University College of Medicine. He received an M.D. degree from Seoul National University College of Medicine (1991). He received Ph.D. in Medical Science at Seoul National University College of Medicine (2001). He has worked as Chief, Department of Nuclear Medicine, National Cancer Center, Korea (2000- 2007). He studied molecular imaging at Pf. Sam Gambhir’s lab as a visiting scientist of Molecular Imaging Program at Stanford (2003-2004). His research areas are in vivo molecular imaging & nanomedicine.

Dr. Liao received her M.S. and Ph.D. degree in Pharmacology from National Yang-Ming University in Taiwan in 2000 and 2011, respectively. Dr Liao was promoted to Associate Researcher in 2008 and also appointed to be the deputy director of Isotope Application Division at Institute of Nuclear Energy Research (INER). Dr Liao’s research is involved diagnostic nuclear medicine in neurology and regulation of IND and NDA for new drug development.

Guy Cloutier obtained his B.Eng. degree in Electrical Engineering (84), and M.Sc. and Ph.D. in Biomedical Engineering (86, 90). Between the years 90-92, he was a post-doctoral fellow at The Pennsylvania State University with Prof. K. Kirk Shung. Dr. Cloutier is Director of the Laboratory of Biorheology and Medical Ultrasonics at the University of Montreal Hospital Research Center, Professor in the Department of Radiology, Radio-oncology and Nuclear Medicine, and Member of the Institute of Biomedical Engineering at the University of Montreal. He has published more than 180 peer-reviewed articles in these fields, holds 12 patents, licensed two technologies, and was recipient of the National Scientist award of the Fonds de la Recherche en Santé du Québec (2004-2009).

Dr. Cohen has a BA in Chemistry from Brooklyn College and an MD from SUNY-Downstate. He is a specialist in Ultrasound with ABR board certification and a Certificate of Added Qualification (CAQ) in Pediatric Imaging.He has attained fellowship status in the American College of Radiology (ACR), the Society of Radiologists in Ultrasound and the American Institute of Ultrasound in Medicine.He is Chairman and Professor of Radiology at University of Tennessee Health Science Center in Memphis. He is Radiologist-in-Chief at LeBonheur Children's Hospital. He is Editor-in-Chief of ACR's CPI educational modules (published 6x/year) and an Associate editor or on the editorial board of J Ultrasound Med, Ultrasound Quarterly, RadioGraphics and ACR's Case-in-Point.

Alberto Cuocolo is full professor of Diagnostic Imaging, director of the Nuclear Medicine and Sport Medicine Unit, director of the Specialization School in Nuclear Medicine and director of the Ph.D. Course in Biomorphological and Surgical Sciences of the University of Naples Federico II in Italy. He is author of more than 330 scientific publications and more than 50 book chapters. He served as president of the Section of Nuclear Medicine of the UEMS and of the European Association of Nuclear Medicine. He is associate editor of the Journal of Nuclear Cardiology, section editor of Current Cardiovascular Imaging Reports, and member of the editorial board of several scientific international journals.

Dr. Luca Filippi works as a Nuclear Medicine Specialist in the Nuclear Medicine Department of “Santa Maria Goretti” Hospital in Latina (Italy). He is an adjunct professor of Technology in Medical Science at the University of Rome “La Sapienza”. Dr. Filippi's main field of interest is the clinical and translational application of imaging with PET/SPECT probes for the identification of pathology (tumors and neurodegenerative disorders) at a molecular level. More recently, he focused on theranostics, the medical discipline combining diagnostics and target-therapy. Dr. Filippi serves as reviewer for several international journals and has over 80 scientific contributions.

Jens Frahm is Director of Biomedizinische NMR Forschungs GmbH (non-profit) at the Max-Planck-Institute for biophysical Chemistry in Göttingen, Germany. His research focusses on the development and application of advanced MRI techniques for noninvasive studies of animals and humans. Already in 1985 his team invented the FLASH (fast low angle shot) MRI technique which allowed for a 100-fold reduction measuring times. Current advances mark another breakthrough toward real-time MRI, i.e. the recording of MRI movies of arbitrary physiologic processes at very high temporal resolution of 10 to 40 milliseconds.

Dr. Gambhir is the Virginia & D.K. Ludwig Professor of Cancer Research, Chairman of Radiology at Stanford University School of Medicine, and heads the Canary Center at Stanford for Cancer Early Detection. He received his medical and doctorate degrees from the University of California, Los Angeles, Medical Scientist Training Program. He has >575 publications in the field and >40 patents pending or granted. An internationally recognized researcher in molecular imaging with over $90 million of NIH funding. His lab has focused on interrogating fundamental molecular events in living subjects. He has developed and clinically translated several multimodality molecular imaging strategies.

David M. Goldenberg, Sc.D., M.D. is Founder and Chairman of Immunomedics, Inc. He also serves as Chief Scientific Officer and Chief Patent Officer of the company. He is Chairman of the Board of Directors of IBC Pharmaceuticals, Inc., a subsidiary of Immunomedics. Dr. Goldenberg was also the founder and president of the Center for Molecular Medicine and Immunology, and its clinical unit, the Garden State Cancer Center. Dr. Goldenberg obtained his M.D. degree, magna cum laude, from the University of Heidelberg School of Medicine in Germany in 1966, and his Sc.D. degree, cum laude, from the University of Erlangen-Nuremberg Faculty of Natural Sciences, Germany in 1965. He has written or co-authored approximately 1,800 journal articles, book chapters, and abstracts on cancer research, detection and treatment, particularly in radioimmunodetection and radioimmunotherapy.

Professor Andrea Laghi is Professor of Radiology at ‘Sapienza’ University of Rome and Medical Director of “Advanced Diagnostic Imaging” Unit at I.C.O.T. University Hospital, Latina/IT. He is also certified in Nuclear Medicine. His research interests lie in Abdominal Imaging and Oncology, including hybrid imaging. He currently is a member of the Executive Committee of ESGAR and ESOI, member of EIBALL, member of Award Committee of RSNA and he is the ESR representative in the EU Expert Group on Cancer Control and ESGAR delegate at the General Assembly of United European Gastroenterology (UEG). Prof. Laghi is Honorary Member of SEDIA, the Spanish Society of Gastrointestinal and Abdominal Radiology, and of the Iranian Society of Radiology.

Prof. Adriaan A. Lammertsma, PhD, is head of research of the Department of Radiology & Nuclear Medicine of the VU University Medical Center in Amsterdam. He has been active in PET research since 1979, when he joined the MRC Cyclotron Unit, Hammersmith Hospital in London. He is the 2012 recipient of the Kuhl-Lassen Award from the Society of Nuclear Medicine for “outstanding contributions to the advancement of molecular imaging” and the 2015 recipient of the ESMI Award from the European Society of Molecular Imaging for “his outstanding and excellent contributions to the field of Imaging Science, his commitment and dedication”. Adriaan Lammertsma is co-author of greater than 400 peer reviewed papers.

Gang Liu received his MD degree from North Sichuan Medical College (China) in 2002 and PhD degree from Sichuan University (China) in 2009. Subsequently, He focused his training on nanomedicine and molecular imaging at the National Institutes of Biomedical Imaging and Bioengineering, National Institutes of Health. In 2012, he joined the Center for Molecular Imaging and Translational Medicine, Xiamen University. Currently he is a Full Professor of Biomedical and Bioengineering and his research interests include biomaterials, theranostics, and molecular imaging.

Dr Franca Podo, Laurea in Physics (DrSci) at the University of Rome “La Sapienza”, has been for about thirty years Research Director at the Istituto Superiore di Sanità (ISS, Rome), where she acted as Head of the “Physical Biochemistry”and “Molecular and Cellular Imaging” Units. She has been Project Leader for three EU Concerted Actions on clinical applications of MRI/MRS; scientific coordinator of the High Breast Cancer Risk Italian studies (HIBCRIT) and PI of research projects on the significance of MRS signals as signatures of cancer metabolic reprogramming and response to treatment (177 publications, 26 book chapters; co-editor of five books).

Dr. Schober obtained a doctorate (Ph.D.) in Physics from the Leibniz University of Hannover, Germany, and finished study of Medicine with a M.D.-Thesis at the Medical School Hannover, Germany. He has published more than 600 scientific publications. Dr. Schober is full Professor of Nuclear Medicine at the University of Münster, Germany. Dr. Schober is also Member and Delegate for Scientific Academies (acatech, National Academy of Science and Engineering; Union of the German Academy of Sciences and Humanities). Dr. Schober was the founding Director of the European Institute for Molecular Imaging (2007). He was and is Editor-in-Chief and Board member of different scientific Journals.

Thomas D. Scholz, M.D., is a pediatric cardiologist. He did post-doctoral training in the Laboratory of Cardiac Energetics at NIH from 1991-1993 before joining the The University of Iowa in 1993. He has held several leadership positions at Iowa including Interim Chairman of the Department of Pediatrics from 2011-2013 and Faculty Fellow in the Office of the Vice President of Research from 2013-2016. He currently serves as Director, Division of Child and Community Health, where he oversees grants and contracts totaling close to $10 million per year to support services for children and youth with special health care needs.

Dr. Ge Wang is Clark & Crossan Chair Professor and the Director of the Biomedical Imaging Center, RPI, USA. He authored the papers on the first spiral/helical cone-beam/multi-slice CT algorithm. Currently, there are over 100 million medical CT scans yearly with a majority in the spiral cone-beam mode. He pioneered bioluminescence tomography. His group published the first papers on interior tomography and omni-tomography (“all-in-one”) to acquire diverse datasets simultaneously (“all-at-once”). His results were featured in Nature, Science, and PNAS, and recognized with awards. He wrote >430 peer-reviewed journal publications. He is Dellow of the IEEE, SPIE, OSA, AIMBE, AAPM, and AAAS.

Mohammad Khosravi is currently an academic researcher/research engineer in the field of statistical signal processing and a senior researcher for SAR technology at the Telecommunications Group, the Department of Electrical and Electronic Engineering, Shiraz University of Technology, Shiraz, Iran. He is also a research associate for multimedia and networking at the Department of Computer Engineering, Persian Gulf University, Bushehr, Iran. He has served/is serving as an international technical program committee member of international conferences including IEEE-ICCC 2017, and SPIE-IWPR 2018. In addition, he is currently serving as a managing editor of special sections for Current Medical Imaging Reviews (CMIR), Current Signal Transduction Therapy (CSTT), and International Journal of Sensors, and Wireless Communications and Control (IJSWCC). His main interests include statistical signal and image processing, medical bioinformatics, radar imaging and satellite remote sensing, computer communications, wireless sensor networks, underwater acoustic communications, information science and scientometrics.